Metraipolis › archive › dc_68f0a034a2bd

Efficacy and safety of B/F/TAF in treatment-naïve and virologically suppressed people with HIV ≥ 50 years of age: integrated analysis from six phase 3… — Europe PMC PMID:40846915

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40846915
DOI: 10.1186/s12879-[numero omesso]-3
License (as archived): solo-consultazione
Archived: 2026-11-10T10:28:45.992Z
SHA-256 of the archived text: 0435188e4e2020625a1e2443130eca9097e421b5fa102dc52e590154f4736bfd
Stable URL of this page: https://metraipolis.com/documento/dc_68f0a034a2bd

How to cite

Efficacy and safety of B/F/TAF in treatment-naïve and virologically suppressed people with HIV ≥ 50 years of age: integrated analysis from six phase 3… — Europe PMC PMID:40846915 — Europe PMC (en), https://europepmc.org/article/MED/40846915 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_68f0a034a2bd (Metraipolis archive dc_68f0a034a2bd, sha256 0435188e4e2020625a1e2443130eca9097e421b5fa102dc52e590154f4736bfd)

BibTeX

@misc{dc68f0a034a2bd,
  title = {Efficacy and safety of B/F/TAF in treatment-naïve and virologically suppressed people with HIV ≥ 50 years of age: integrated analysis from six phase 3… — Europe PMC PMID:40846915},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40846915},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_68f0a034a2bd; sha256 0435188e4e2020625a1e2443130eca9097e421b5fa102dc52e590154f4736bfd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40846915. Agents can read the archived copy with the MCP tool read_document.